Victory Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Victory Capital Management's DYN Position: Q3 2026 in Review
Victory Capital Management increased its Dyne Therapeutics (DYN) stake by 166% in Q3 2026, buying an estimated $2.08M and bringing the position to 145,077 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1613.
Victory Capital Management first reported a position in DYN in Q2 2024 and has held it in 10 quarters since. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Victory Capital Management held 145,077 shares of Dyne Therapeutics worth $2.34M as of Q3 2026.
- Victory Capital Management bought 90,579 Dyne Therapeutics shares in Q3 2026, an estimated $2.08M.
- Dyne Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1613 holding.
- Victory Capital Management first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 10 quarters since.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.